ProShare Advisors LLC Reduces Holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
ProShare Advisors LLC cut its position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 19.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,020 shares of the biopharmaceutical company’s stock after selling 1,224 shares during the quarter. ProShare Advisors […]
ProShare Advisors LLC cut its position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 19.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,020 shares of the biopharmaceutical company’s stock after selling 1,224 shares during the quarter. ProShare Advisors […]
